Elanco Animal Health Closes Sale Of Aqua Business To Merck Animal Health
RTTNews
|
812 hari yang lalu
(RTTNews) - Elanco Animal Health, Inc. (ELAN) announced Tuesday it has completed the divestiture of its aqua business to Merck Animal Health (MRK) for approximately $1.3 billion in cash, with approximately $1.05 billion to $1.1 billion in net proceeds available for debt paydown in the third quarter of 2024.
The successful completion of this transaction enables the company to pay down term loan debt on a pro-rata basis per the terms of the company's credit agreements.
Combined with the expected $280 million to $320 million of cash generated from the base business, the company expects to pay down approximately $1.3 billion to $1.4 billion of debt in 2024.
baca selengkapnya
Elanco Animal Health Boosts FY23 Adj. EPS, Revenue Outlook As Q3 Results Top Estimates
Elanco Animal Health Inc. (ELAN) reported Tuesday a net loss for the third quarter of $1.10 billion or $2.22 per share, sharply wider than $65.0 million or $0.13 per share in the prior-year quarter.
RTTNews
|
1057 hari yang lalu
Elanco's Canine Parvovirus Treatment Gets USDA License
Elanco Animal Health Inc. announced that the U.S. Department of Agriculture or USDA has issued a conditional license for its Canine Parvovirus Monoclonal Antibody. The company expects to begin shipping Canine Parvovirus Monoclonal Antibody in the coming weeks, pending individual state approvals. The targeted single-dose monoclonal antibody is the first and only approved targeted therapeutic...
RTTNews
|
1245 hari yang lalu
FDA Approves First Drug For Anemia In Cats With CKD
The U.S. Food and Drug Administration conditionally approved Elanco US Inc.'s Varenzin-CA1 (molidustat oral suspension) for treating anemia in cats with chronic kidney disease or CKD. It is the first drug for the control of nonregenerative anemia associated with CKD in cats. Varenzin-CA1 works by helping to increase production of erythropoietin in the kidney, which in turn stimulates the bone mar
RTTNews
|
1246 hari yang lalu
UK Mortgage Approvals Fall To 32-Month Low
UK mortgage approvals declined to a 32-month low in August amid higher borrowing costs, while consumer credit reached a record high, data from the Bank of England showed Tuesday. Net mortgage approvals for house purchases, an indicator of future borrowing, fell unexpectedly to 54,918 in August from 55,928 in the previous month.
RTTNews
|
7 menit yang lalu
Mixed Sentiment In Asian Markets
Mixed sentiment prevailed in Asian markets on Tuesday tracking the negative sentiment in Wall Street on Monday. Market mood was impacted by worries about a broad slowdown in AI development. Markets also digested the rate hike by Reserve Bank of Australia. Renewed diplomatic push to end the Middle East crisis, the decline in crude oil prices and the easing in bond yields capped losses.
RTTNews
|
14 menit yang lalu
Sensex, Nifty Come Off Early Lows, But Close Weak For 2nd Straight Session
Indian shares closed weak on Tuesday, extending recent losses, amid concerns about inflation due to elevated oil prices. Sustained selling by foreign portfolio investors weighed as well on stocks.
RTTNews
|
31 menit yang lalu
FTSE 100 Modestly Higher As Miners, Pharma Stocks Move Up
The U.K. stock market's benchmark index FTSE 100 climbed higher on Tuesday, led by gains in mining and pharmaceuticals sectors even as the mood remained somewhat cautious amid a lack of progress in U.S.-Iran negotiations to reopen the Strait of Hormuz.
RTTNews
|
1 jam 4 menit yang lalu
U.S. Dollar Rises Amid Fed Rate Hike Speculation
The U.S. dollar strengthened against most major currencies in the European session on Tuesday, as traders anticipate that the Federal Reserve (Fed) will raise interest rates twice more this year.
RTTNews
|
1 jam 26 menit yang lalu







